NIH-funded research R01 grant

Atrial heart proteins and how they control heartbeats

Official title: SPECIFIC REGULATION OF CARDIAC ATRIAL CONTRACTILITY

Funded at Loyola University Chicago · NIH-11412630 · Data updated 2026-11-12

A research grant explores how specific atrial heart proteins control atrial contraction and may influence arrhythmias and cardiomyopathy in humans.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLoyola University Chicago
NIH-funded
Lab location1 site (Maywood, United States)
Project startSeptember 10, 2025
Project endJune 30, 2030
Funding year2026
Award (this year)$606,357
NIH project number5R01HL181346-02
Project IDNIH-11412630 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with hereditary or suspected hereditary cardiomyopathy or atrial fibrillation, who may contribute tissue samples or participate in related future studies.

Less likely to help

People with non-atrial heart conditions or without genetic cardiomyopathy involvement may not directly benefit.

What this research studies

This project looks at how atrial-specific proteins, especially myosin binding protein-H-like, affect the force and regulation of atrial muscle. Researchers will examine how the amino-terminal region of these proteins interacts with the heart’s sarcomere and alters muscle force and the relaxed state of myosin. The study uses human and mouse samples to understand how mutations in these atrial proteins relate to atrial fibrillation and cardiomyopathy, aiming to uncover mechanisms that could guide future therapies. The work builds on prior findings showing a 1:1 balance of certain myosin-binding sites between human and mouse atria and will define when and how these regions regulate heart function.

Why it matters

Potential benefit: A deeper understanding of atrial regulation could lead to new targets for treating atrial fibrillation and related heart diseases.

How similar studies have gone: Previous work linked atrial-specific proteins to arrhythmias and cardiomyopathy, suggesting this approach could be informative, though the exact mechanisms remain to be clarified.

Where this research is happening

  • Loyola University Chicago
    Maywood, United States
    Active

Researchers

  • Principal investigator: Barefield, David Y — Loyola University Chicago
  • Study coordinator: Barefield, David Y

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.